TNF and rheumatic disorder: Furthermore, it was later shown that deletion of TNF-α or its receptor protects mice against diet-induced obesity and insulin resistance [28], whereas TNF-α blockade by treatment with its monoclonal antibody infliximab improved glucose homeostasis in patients with rheumatic disease [29–32].